- Home
- INVA vs PCT Comparison
INVA vs PCT Comparison
Compare INVA & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INVA
- PCT
- Stock Information
- Founded
- INVA 1996
- PCT 2015
- Country
- INVA United States
- PCT United States
- Employees
- INVA N/A
- PCT N/A
- Industry
- INVA Biotechnology: Pharmaceutical Preparations
- PCT Environmental Services
- Sector
- INVA Health Care
- PCT Utilities
- Exchange
- INVA Nasdaq
- PCT Nasdaq
- Market Cap
- INVA 1.2B
- PCT 1.1B
- IPO Year
- INVA 2004
- PCT N/A
- Fundamental
- Price
- INVA $21.58
- PCT $9.88
- Analyst Decision
- INVA Buy
- PCT Strong Buy
- Analyst Count
- INVA 1
- PCT 4
- Target Price
- INVA $55.00
- PCT $12.50
- AVG Volume (30 Days)
- INVA 815.1K
- PCT 3.4M
- Earning Date
- INVA 07-30-2025
- PCT 05-07-2025
- Dividend Yield
- INVA N/A
- PCT N/A
- EPS Growth
- INVA N/A
- PCT N/A
- EPS
- INVA N/A
- PCT N/A
- Revenue
- INVA $369,844,000.00
- PCT $1,580,000.00
- Revenue This Year
- INVA $3.75
- PCT N/A
- Revenue Next Year
- INVA $12.62
- PCT $26.46
- P/E Ratio
- INVA N/A
- PCT N/A
- Revenue Growth
- INVA 18.70
- PCT N/A
- 52 Week Low
- INVA $15.56
- PCT $4.50
- 52 Week High
- INVA $21.60
- PCT $15.58
- Technical
- Relative Strength Index (RSI)
- INVA 86.95
- PCT 62.16
- Support Level
- INVA $18.59
- PCT $9.60
- Resistance Level
- INVA $19.08
- PCT $10.21
- Average True Range (ATR)
- INVA 0.42
- PCT 0.63
- MACD
- INVA 0.25
- PCT 0.01
- Stochastic Oscillator
- INVA 99.35
- PCT 74.34
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
About PCT PureCycle Technologies Inc. Common stock
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.